Ankle osteochondral lesion repair with a bone marrow–enriched scaffold and retrograde drilling
Official title: Evaluation of the Osteointegrative and Regenerative Capacity of a Scaffold Enriched With Bone Marrow-Derived Cells at the Subchondral Level, Associated With Retrograde Drilling
Run by Istituto Ortopedico Rizzoli · NCT07555899 · Data updated 2026-11-12
This approach will try a bone marrow–enriched scaffold combined with retrograde drilling to repair ankle osteochondral lesions in adults aged 18–55 with subchondral cysts or intact cartilage.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 55 Years |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | Istituto Ortopedico Rizzoli Academic / other |
| Locations | 1 site (Bologna) |
| Status | Recruiting |
| Started | January 30, 2026 |
| Main results expected | January 2028 |
| Study ends | February 2028 |
| Registry record updated | April 29, 2026 |
| Trial ID | NCT07555899 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–55 with chronic talar subchondral cysts or large osteochondral lesions with intact or stable cartilage and impaired daily function who can give informed consent are ideal candidates.
✕Probably not a fit
Patients with damaged or unstable articular cartilage, active infection, age outside 18–55, or other exclusion criteria are unlikely to benefit from this specific procedure.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The procedure fills subchondral talar defects with a scaffold seeded with autologous bone marrow‑derived cells and creates channels via retrograde drilling to stimulate bone and cartilage repair. The retrograde, extra‑articular technique is intended to reach cystic lesions while preserving an intact cartilage surface. Patients undergo bone marrow aspiration, scaffold preparation and placement at the Rizzoli Orthopaedic Institute, followed by clinical follow‑up. Functional and quality‑of‑life scores such as AOFAS and SF‑36 will be used to monitor outcomes.
Why it matters
Potential benefit: If successful, this technique could reduce pain and improve ankle function by promoting subchondral bone regeneration while avoiding damage to intact cartilage.
How similar studies have gone: Retrograde drilling is an established option for subchondral cysts and small studies of bone marrow‑enriched scaffolds have shown promising but not definitive results, so the combined approach is plausible but not yet proven.
Who can join: the full rules
Show full inclusion / exclusion criteria
All patients diagnosed with subchondral cysts with intact cartilage or massive osteochondral lesions (OCLs) of the ankle joint treated with retrograde drilling and application of bone marrow aspirate on a scaffold at the First Clinic of the Rizzoli Orthopaedic Institute in Bologna will be included, in accordance with the criteria specified below. INCLUSION CRITERIA: Patients with one or more chronic cystic subchondral lesions of the talus (Grade IIA according to the Giannini classification); Patients with one or more chronic subchondral lesions with intact cartilage or large chronic OCLs (Grade IIA according to the Giannini classification); Age ≥ 18 years and ≤ 55 years; Ankle pain with limitation in normal activities of daily living (American Orthopaedic Foot and Ankle Score - AOFAS \< 85, Short Form-36 - SF-36 \< 86); Patients able to provide written informed consent to participate in the study. EXCLUSION CRITERIA: Patients \< 18 years or \> 55 years of age; Presence of active infections at the time of study inclusion; Positive status for HIV, HBV, or HCV; Pregnancy; Patients with autoimmune or rheumatologic diseases; Disorders of the immune system; Presence of severe malalignment of the tibiotalar joint in the coronal plane, whether supra-, intra-, or infra-articular (distal tibial articular angle \< or \> 10°, talar tilt \> 8°, severe cavus or flatfoot); Any other condition or disease that contraindicates surgical treatment.
Where it's running
-
Istituto Ortopedico Rizzoli
Bologna, Italy Recruiting
Study contacts
- Study coordinator: Antotnio Mazzotti, MD PhD
- Email: antonio.mazzotti@ior.it
- Phone: +39 349 879 8863
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Archive of Custom-Made Guides for Orthopedic Surgery
Researchers are testing a digital archive to store and track patient-specific cutting guides used in orthopedic surgeries for people with bone deformities.
-
Use of reconstructive microsurgery to treat lymphedema
This study tests whether reconstructive microsurgery, with or without the help of indocyanine green imaging, can help people with lymphedema feel and function better by improving lymphatic drainage.
-
ACL reconstruction using the Over-The-Top technique with either metal staples or soft anchors
This study tests whether using a suture-based fixation (soft anchors) during OTT ACL reconstruction works as well as metal staples for graft stability in adults aged 18–50.
-
Biomarkers in circulating vesicles for Ewing sarcoma
Researchers will test blood samples from people with Ewing sarcoma to see if circulating biomarkers in extracellular vesicles can help validate new therapies.
-
Differences in Outcomes After Allograft vs Autograft in Revision ACL Repair
This study looks at whether using donor tissue (allograft) versus the patient’s own tissue (autograft) in revision ACL surgery leads to different results.
-
Hip arthroplasty with a short cementless stem using a direct anterior approach
This study tests whether a short, cementless hip stem implanted through a minimally invasive direct anterior approach works well in adults with hip arthritis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.